Company intelligence / Profile preview

The ODIN

Austin, Texas, United Statesthe-odin.com ↗

Ownership: Private
Development stage: Other

Overview

The ODIN sells genetic engineering and gene-editing kits directly to consumers and educators. It aims to democratize access to biotechnology by making it possible for anyone—at home or in the lab—to experiment with genetic modification. No clinical results as it does not develop drugs.

Modalities: CRISPR-based tools/kitsGene editing tools/kitsGenomics tools/kits
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on The ODIN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The ODIN.

Explore the full profile